BRPI0812432A2 - Extrudados com mascaramento de sabor melhorado - Google Patents

Extrudados com mascaramento de sabor melhorado

Info

Publication number
BRPI0812432A2
BRPI0812432A2 BRPI0812432-9A2A BRPI0812432A BRPI0812432A2 BR PI0812432 A2 BRPI0812432 A2 BR PI0812432A2 BR PI0812432 A BRPI0812432 A BR PI0812432A BR PI0812432 A2 BRPI0812432 A2 BR PI0812432A2
Authority
BR
Brazil
Prior art keywords
extruded
improved flavor
flavor masking
masking
improved
Prior art date
Application number
BRPI0812432-9A2A
Other languages
English (en)
Inventor
Venkata-Rangarao Kanikanti
Hans-Juergen Hamann
Peter Kleinebudde
Andrea Michalk
Claudia Reitz
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39790368&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0812432(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Publication of BRPI0812432A2 publication Critical patent/BRPI0812432A2/pt
Publication of BRPI0812432B1 publication Critical patent/BRPI0812432B1/pt
Publication of BRPI0812432B8 publication Critical patent/BRPI0812432B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Seasonings (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Fats And Perfumes (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BRPI0812432A 2007-06-08 2008-05-28 extrusados, seu uso, e medicamento BRPI0812432B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102007026550A DE102007026550A1 (de) 2007-06-08 2007-06-08 Extrudate mit verbesserter Geschmacksmaskierung
DE102007026550.8 2007-06-08
PCT/EP2008/004218 WO2008148484A1 (de) 2007-06-08 2008-05-28 Extrudate mit verbesserter geschmacksmaskierung

Publications (3)

Publication Number Publication Date
BRPI0812432A2 true BRPI0812432A2 (pt) 2014-12-02
BRPI0812432B1 BRPI0812432B1 (pt) 2019-04-16
BRPI0812432B8 BRPI0812432B8 (pt) 2021-05-25

Family

ID=39790368

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0812432A BRPI0812432B8 (pt) 2007-06-08 2008-05-28 extrusados, seu uso, e medicamento

Country Status (36)

Country Link
US (1) US20100197571A1 (pt)
EP (1) EP2170272B1 (pt)
JP (2) JP5775302B2 (pt)
KR (2) KR20150110825A (pt)
CN (1) CN101677946A (pt)
AR (1) AR066914A1 (pt)
AU (1) AU2008258887B2 (pt)
BR (1) BRPI0812432B8 (pt)
CA (1) CA2689486C (pt)
CL (1) CL2008001575A1 (pt)
CO (1) CO6260054A2 (pt)
CR (1) CR11096A (pt)
DE (1) DE102007026550A1 (pt)
DK (1) DK2170272T3 (pt)
DO (1) DOP2009000255A (pt)
EC (1) ECSP099716A (pt)
ES (1) ES2625138T3 (pt)
GT (1) GT200900287A (pt)
HR (1) HRP20170747T1 (pt)
HU (1) HUE032719T2 (pt)
IL (1) IL201708A0 (pt)
MX (1) MX2009011999A (pt)
MY (1) MY157780A (pt)
NI (1) NI200900198A (pt)
NZ (1) NZ581670A (pt)
PE (1) PE20090761A1 (pt)
PL (1) PL2170272T3 (pt)
PT (1) PT2170272T (pt)
RU (2) RU2009148576A (pt)
SI (1) SI2170272T1 (pt)
SV (1) SV2009003403A (pt)
TW (1) TWI483738B (pt)
UA (1) UA97401C2 (pt)
UY (1) UY31117A1 (pt)
WO (1) WO2008148484A1 (pt)
ZA (1) ZA200908647B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2172191A1 (en) * 2008-10-01 2010-04-07 Heinrich-Heine-Universität Düsseldorf Lipid pellets with enhanced taste-masking
WO2010063387A1 (de) * 2008-12-05 2010-06-10 Bayer Animal Health Gmbh Extrudate mit nadelförmigen wirkstoffen
DE102009012423A1 (de) * 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
HU231017B1 (hu) 2012-05-08 2019-11-28 LAVET Gyógyszeripari Kft. Praziquantel tartalmú ízfedett formulációk
CA2910865C (en) 2014-07-15 2016-11-29 Isa Odidi Compositions and methods for reducing overdose
EP3181317A1 (de) * 2015-12-18 2017-06-21 LANXESS Deutschland GmbH Verfahren zur herstellung von feststoffpartikeln
CN108888598A (zh) * 2018-08-01 2018-11-27 江西成必信生物科技有限公司 口服易吸收的布他磷及其制备方法
CN111529499B (zh) * 2020-06-11 2021-09-17 华中农业大学 一种兽用恩诺沙星风味片剂及其制备方法
JP2023540312A (ja) 2020-09-04 2023-09-22 エランコ・ユーエス・インコーポレイテッド 口当たりの良い製剤

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5746986A (en) 1980-09-02 1982-03-17 Dai Ichi Seiyaku Co Ltd Pyrido(1,2,3-de)(1,4)benzoxazine derivative
US4670444B1 (en) 1980-09-03 1999-02-09 Bayer Ag and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds
US4472405A (en) 1982-11-12 1984-09-18 Riker Laboratories, Inc. Antimicrobial 6,7-dihydro-5,8-dimethyl-9 fluoro-1-oxo-1H, 5H-benzo (ij) quinolizine-2-carboxylic acid and derivatives
US4730000A (en) 1984-04-09 1988-03-08 Abbott Laboratories Quinoline antibacterial compounds
AT392789B (de) 1985-01-23 1991-06-10 Toyama Chemical Co Ltd Verfahren zur herstellung von 1-substituierten aryl-1,4-dihydro-4-oxonaphthyridinderivaten
JPS61240963A (ja) * 1985-04-18 1986-10-27 ユニチカ株式会社 創傷被覆保護材
IN166416B (pt) 1985-09-18 1990-05-05 Pfizer
JP2579610B2 (ja) * 1990-09-28 1997-02-05 鳥取大学長 生体内充填剤
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
AUPM969994A0 (en) * 1994-11-28 1994-12-22 Virbac S.A. Equine anthelmintic formulations
JP3418274B2 (ja) * 1995-06-05 2003-06-16 日本化薬株式会社 口腔内感触の良好な錠剤
CZ291251B6 (cs) * 1996-02-23 2003-01-15 Bayer Aktiengesellschaft Popřípadě substituované 8-kyan-1-cyklopropyl-7-(2,8-diazabicyklo-[4,3,0]-nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolinkarboxylové kyseliny a jejich deriváty, způsob jejich výroby, léčiva tyto látka obsahující a jejich pouľití
DE19628776A1 (de) 1996-07-17 1998-01-22 Bayer Ag Oral applizierbare Granulate von Hexahydropyrazinderivaten
EP0959891A1 (en) * 1996-07-30 1999-12-01 Ashmont Holdings Limited Anthelmintic formulations
FR2753904B1 (fr) 1996-10-01 1998-10-30 Gattefosse Ets Sa Composition pharmaceutique a liberation modifiee de principe actif, comportant une matrice, et procede de fabrication
CA2227314A1 (en) 1997-01-24 1998-07-24 Hoechst Aktiengesellschaft Preparation of concealed taste preparations of antibacterially active quinolone derivatives
US6171615B1 (en) 1998-07-06 2001-01-09 Gattefoss{acute over (e)} Sustained release theophylline formulations, excipient systems and methods of production
WO2000006122A1 (en) * 1998-07-31 2000-02-10 Otsuka Pharmaceutical Co., Ltd. Pharmaceutical composition having improved taste
DE19854355A1 (de) 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
US6500463B1 (en) * 1999-10-01 2002-12-31 General Mills, Inc. Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles
CA2413702A1 (en) * 2000-06-28 2002-01-03 Teva Pharmaceuticals Industries Ltd. Carvedilol
US20020122824A1 (en) 2001-01-24 2002-09-05 Francisco Cabrera Solid phase dispersion of quinolone-or naphthyridonecarboxylic acids
ES2439725T3 (es) 2001-10-05 2014-01-24 Rubicon Scientific Llc Piensos para animales que incluyen principios activos
US6716448B2 (en) * 2001-10-05 2004-04-06 Rubicon Scientific Llc Domesticated household pet food including maintenance amounts of ivermectin
DE10208344A1 (de) 2002-02-27 2003-09-04 Roehm Gmbh Schmelzextrusion von Wirkstoffsalzen
US20030190343A1 (en) 2002-03-05 2003-10-09 Pfizer Inc. Palatable pharmaceutical compositions for companion animals
JP2004099442A (ja) * 2002-09-04 2004-04-02 Nisshin Pharma Inc 難溶性薬物含有製剤およびその製造方法
US20040062778A1 (en) * 2002-09-26 2004-04-01 Adi Shefer Surface dissolution and/or bulk erosion controlled release compositions and devices
BR0317177A (pt) * 2002-12-13 2005-10-25 Cilag Ag Preparações de liberação controlada compreendendo tramadol e topiramato
DE10304403A1 (de) * 2003-01-28 2004-08-05 Röhm GmbH & Co. KG Verfahren zur Herstellung einer oralen Arzneiform mit unmittelbarem Zerfall und Wirkstofffreisetzung
MY135852A (en) * 2003-04-21 2008-07-31 Euro Celtique Sa Pharmaceutical products
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
US20050163842A1 (en) * 2003-12-31 2005-07-28 Garth Boehm Rosiglitazone and metformin formulations
JP4210615B2 (ja) * 2004-03-26 2009-01-21 エスエス製薬株式会社 不快な味がマスキングされた製剤
DE102004015981A1 (de) 2004-04-01 2005-10-20 Bayer Healthcare Ag Neue kirstalline Form von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE602005003343T2 (de) * 2004-04-12 2008-09-11 Pfizer Products Inc., Groton Arzneiimittel mit verdecktem geschmack in aufbrechenden multipartikeln
GB2418854B (en) * 2004-08-31 2009-12-23 Euro Celtique Sa Multiparticulates
JP4731941B2 (ja) * 2005-02-14 2011-07-27 大正薬品工業株式会社 経口製剤用粒子
US8900637B2 (en) * 2005-12-02 2014-12-02 Lupin Limited Stable taste masked formulations of cephalosporins

Also Published As

Publication number Publication date
CR11096A (es) 2010-06-28
KR101600800B1 (ko) 2016-03-08
MX2009011999A (es) 2009-11-19
AU2008258887A1 (en) 2008-12-11
US20100197571A1 (en) 2010-08-05
ECSP099716A (es) 2009-12-28
EP2170272A1 (de) 2010-04-07
CA2689486C (en) 2016-03-22
EP2170272B1 (de) 2017-03-29
DE102007026550A1 (de) 2008-12-11
PE20090761A1 (es) 2009-07-23
RU2014124814A (ru) 2015-12-27
PL2170272T3 (pl) 2017-08-31
NZ581670A (en) 2012-07-27
CL2008001575A1 (es) 2008-12-19
SI2170272T1 (sl) 2017-06-30
HRP20170747T1 (hr) 2017-07-28
AR066914A1 (es) 2009-09-23
TW200914051A (en) 2009-04-01
AU2008258887B2 (en) 2014-06-26
CO6260054A2 (es) 2011-03-22
RU2009148576A (ru) 2011-07-20
BRPI0812432B1 (pt) 2019-04-16
KR20100017385A (ko) 2010-02-16
JP5775302B2 (ja) 2015-09-09
CN101677946A (zh) 2010-03-24
MY157780A (en) 2016-07-29
UY31117A1 (es) 2009-01-30
WO2008148484A1 (de) 2008-12-11
NI200900198A (es) 2011-12-14
DOP2009000255A (es) 2009-12-15
GT200900287A (es) 2011-11-09
HUE032719T2 (en) 2017-10-30
IL201708A0 (en) 2010-05-31
DK2170272T3 (en) 2017-06-06
TWI483738B (zh) 2015-05-11
JP2010529059A (ja) 2010-08-26
CA2689486A1 (en) 2008-12-11
ZA200908647B (en) 2011-02-23
BRPI0812432B8 (pt) 2021-05-25
UA97401C2 (ru) 2012-02-10
PT2170272T (pt) 2017-05-24
KR20150110825A (ko) 2015-10-02
SV2009003403A (es) 2010-05-17
ES2625138T3 (es) 2017-07-18
JP2014114310A (ja) 2014-06-26

Similar Documents

Publication Publication Date Title
DK2064228T3 (da) Syntetiske peptidamider
BRPI0818380A2 (pt) Combinação de herbicida-protetor
BRPI0820483A2 (pt) Variantes de glicoamilase com propriedades alteradas
BRPI0813707A2 (pt) Derivados de pirimidinil-piridazinona
BRPI0820112A2 (pt) Derivados de isoxazol-piridina
BRPI0809992A2 (pt) Derivados de pirrolopirimidina
BRPI0820113A2 (pt) Derivados de isoxazolo-piridazina
DOS2008000026S (es) Confiteria
BRPI0810191A2 (pt) Escova de dentes
BRPI0817935A2 (pt) Derivados de biarila
BRPI0812155A2 (pt) derivados de espiroindolinona
BRPI0812518A2 (pt) Derivados de indazolamida
BRPI0814236A2 (pt) Derivados de quinazolinamida
BRPI0820649A2 (pt) Derivados de isoxazalo-pirazina
BRPI0917977A2 (pt) extrusor de parafuso único
BRPI0812432A2 (pt) Extrudados com mascaramento de sabor melhorado
BRPI0806538A2 (pt) Derivados de glicinamida de espiropiperidina
BRPI0814718A2 (pt) Derivados de isoxazol-imidazol
BRPI0912231A2 (pt) engrenagem de extrusora
FI20075086L (fi) Aromikoostumus
BRPI0811214A2 (pt) Derivados de pirazolona
BRPI0812827A2 (pt) Derivados de macrolactona
BRPI0812816A2 (pt) Derivados de sulfonil-quinolina
DE602007009636D1 (de) Sektionaltor
BRPI0816058A2 (pt) Derivados de tiadiazinona

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: BAYER INTELLECTUAL PROPERTY GMBH (DE)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 16/04/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 16/04/2019, OBSERVADAS AS CONDICOES LEGAIS

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 28/05/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B25G Requested change of headquarter approved

Owner name: BAYER INTELLECTUAL PROPERTY GMBH (DE)

B25A Requested transfer of rights approved

Owner name: BAYER ANIMAL HEALTH GMBH (DE)

B25D Requested change of name of applicant approved

Owner name: ELANCO ANIMAL HEALTH GMBH (DE)

B25G Requested change of headquarter approved

Owner name: ELANCO ANIMAL HEALTH GMBH (DE)